• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Segment 6- Competition in the Marketplace

Article

Dr Fendrick asked panelists what they think about the idea of centers of excellence for specific cancers and an evidence-based steerage.

Dr Fendrick asked panelists what they think about the idea of centers of excellence for specific cancers and an evidence-based steerage. “There may be a value in having a centralized guidance of treatments adapted to a particular patient,” said Dr Ribas. Dr Ribas also discussed the effect future agents being developed for the treatment of melanoma will have on the market. He says prices will be adapted to the benefit due to more competition in the marketplace.

“Perhaps there is some relief on the horizon in terms of pricing because of competition,” said Dr Weber. “Classic essence of capitalism.”

Related Videos
Joshua K. Sabari, MD
Nicoletta Colombo, MD, PhD
 Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
Marc S. Raab, MD, PhD, University Hospital Heidelberg
Chicago skyline with words "CHEST 2025 Recap Chicago, Illinois" | Image credit: SeanPavonePhoto - stock.adobe.com
James Simon, MD – Image credit: AJMC
Brooke Aggarwal, EdD – screenshot by AJMC
Hearn Jay Cho, MD, PhD
Susan Cantrell, CEO of AMCP
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.